1. Home
  2. IRIX vs HBIO Comparison

IRIX vs HBIO Comparison

Compare IRIX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • HBIO
  • Stock Information
  • Founded
  • IRIX 1989
  • HBIO 1901
  • Country
  • IRIX United States
  • HBIO United States
  • Employees
  • IRIX N/A
  • HBIO N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • IRIX Health Care
  • HBIO Industrials
  • Exchange
  • IRIX Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • IRIX 16.5M
  • HBIO 16.9M
  • IPO Year
  • IRIX 1996
  • HBIO 2000
  • Fundamental
  • Price
  • IRIX $1.22
  • HBIO $0.38
  • Analyst Decision
  • IRIX Hold
  • HBIO Buy
  • Analyst Count
  • IRIX 1
  • HBIO 2
  • Target Price
  • IRIX $2.00
  • HBIO $4.50
  • AVG Volume (30 Days)
  • IRIX 98.8K
  • HBIO 361.4K
  • Earning Date
  • IRIX 05-13-2025
  • HBIO 05-06-2025
  • Dividend Yield
  • IRIX N/A
  • HBIO N/A
  • EPS Growth
  • IRIX N/A
  • HBIO N/A
  • EPS
  • IRIX N/A
  • HBIO N/A
  • Revenue
  • IRIX $48,669,000.00
  • HBIO $94,135,000.00
  • Revenue This Year
  • IRIX $9.61
  • HBIO N/A
  • Revenue Next Year
  • IRIX N/A
  • HBIO $8.58
  • P/E Ratio
  • IRIX N/A
  • HBIO N/A
  • Revenue Growth
  • IRIX N/A
  • HBIO N/A
  • 52 Week Low
  • IRIX $0.78
  • HBIO $0.36
  • 52 Week High
  • IRIX $3.25
  • HBIO $4.08
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 62.01
  • HBIO 30.36
  • Support Level
  • IRIX $0.98
  • HBIO $0.56
  • Resistance Level
  • IRIX $1.26
  • HBIO $0.42
  • Average True Range (ATR)
  • IRIX 0.09
  • HBIO 0.05
  • MACD
  • IRIX 0.04
  • HBIO 0.02
  • Stochastic Oscillator
  • IRIX 91.49
  • HBIO 13.00

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: